The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)
Recruiting
N/A
Interventional Study
Kidney Failure, Acute
Myopathy; Drugs
Heart Arrhythmia
Succinylcholine Sensitivity
Muscle Relaxation
General Anesthetic Drug Adverse Reaction
Projection
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 90
- Sex
- Any
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 32 (estimated)
- Sponsor
- 4th Military Clinical Hospital with Polyclinic, Poland · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study aims to improve the safety of the electroporation ablation (PFA) procedure by using muscle relaxants to reduce skeletal muscle damage during the procedure. It will also assess myocardial damage to improve the procedure's quality and speed up recovery after the procedure.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with requirement for PFA ablation for cardiac indications and ability to provide informed consent for study participation
Exclusion Criteria:
* Patients with allergies to the general anaesthetics used, genetic diseases of the neuromuscular plateau - e.g. Duchenne dy…
Contacts